In this study of 16 patients with chronic HCV genotype 1 infection who were undergoing liver transplantation from an HCV-negative donor, a 4-week course of once-daily ledipasvir–sofosbuvir achieved a sustained virologic response in 14 of the 15 patients who completed treatment.
No takes yet. Share an insight, caveat, or question.
Levitsky et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: